Difference between revisions of "Godfrey Kigozi"
m (using Template:PhD) |
(using Template:Population-based studies) |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | '''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.<ref>{{REFweb | + | '''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male [[Adolescent and adult circumcision| circumcision]] for [[HIV]] prevention and related service delivery for adolescent boys and men in generalized [[HIV]] epidemics.<ref>{{REFweb |
|url=https://www.who.int/hiv/mediacentre/news/gdg-male-circumcision/en/ | |url=https://www.who.int/hiv/mediacentre/news/gdg-male-circumcision/en/ | ||
|title=WHO to develop new guidelines on male circumcision | |title=WHO to develop new guidelines on male circumcision | ||
| Line 10: | Line 10: | ||
<blockquote>'''Kigozi, Godfrey''' | <blockquote>'''Kigozi, Godfrey''' | ||
| − | * Rakai Health Sciences Organization | + | * Rakai Health Sciences Organization, Kampala, Uganda |
| − | * Makerere University, Kampala, Uganda | + | * {{MBChB}}, {{UNI|Makerere University|Mak}}, Kampala, Uganda; <br>{{MPH}}, [[Johns Hopkins Bloomberg School for Public Health]], Baltimore, USA; <br> {{PhD}}, {{UNI|Makerere University|Mak}}/[[Johns Hopkins Bloomberg School for Public Health]]. |
| − | |||
Godfrey Kigozi ({{MPH}}, {{PhD}}) is Head of Research and Technical advisor for Voluntary Medical Male circumcision ([[VMMC]]) at [[Rakai Project|Rakai Health Sciences Program]] in Uganda. | Godfrey Kigozi ({{MPH}}, {{PhD}}) is Head of Research and Technical advisor for Voluntary Medical Male circumcision ([[VMMC]]) at [[Rakai Project|Rakai Health Sciences Program]] in Uganda. | ||
| − | His focus is on HIV epidemiology and prevention. He has experience in design and conduct of complex research studies including randomized controlled trials, longitudinal cohort studies, and implementation evaluation. He is an investigator on a number NIH and [[Bill & Melinda Gates Foundation|Gates foundation]] [[VMMC]] study protocols that are being implemented in Rakai, Uganda. Godfrey has authored over 150 papers in peer reviewed journals most in the field of [[VMMC]]. (https://www.ncbi.nlm.nih.gov/myncbi/collections/mybibliography/?reload=addfrompubmed&sortby=date&groupby=citation_type) | + | His focus is on [[HIV]] epidemiology and prevention. He has experience in design and conduct of complex research studies including randomized controlled trials, longitudinal cohort studies, and implementation evaluation. He is an investigator on a number NIH and [[Bill & Melinda Gates Foundation|Gates foundation]] [[VMMC]] study protocols that are being implemented in Rakai, Uganda. Godfrey has authored over 150 papers in peer reviewed journals most in the field of [[VMMC]]. (https://www.ncbi.nlm.nih.gov/myncbi/collections/mybibliography/?reload=addfrompubmed&sortby=date&groupby=citation_type) |
| − | Godfrey has experience in design, implementation and management of HIV prevention programs, including [[VMMC]] programs. Godfrey is currently involved in development of a comprehensive national adult and infant [[VMMC]] skills training curriculum. The curriculum will be used to equip VMMC providers with skills in provision of safe [[VMMC]] using surgical and approved device methods as well as skills to provide emergency resuscitation.<ref>{{REFdocument | + | Godfrey has experience in design, implementation and management of [[HIV]] prevention programs, including [[VMMC]] programs. Godfrey is currently involved in development of a comprehensive national adult and infant [[VMMC]] skills training curriculum. The curriculum will be used to equip VMMC providers with skills in provision of safe [[VMMC]] using surgical and approved device methods as well as skills to provide emergency resuscitation.<ref>{{REFdocument |
|url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1 | |url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1 | ||
|title=Biographies of Guideline Development Group (GDG) members for WHO guidance | |title=Biographies of Guideline Development Group (GDG) members for WHO guidance | ||
| Line 28: | Line 27: | ||
</blockquote> | </blockquote> | ||
| − | Kigozi has been closely associated with the Rakai project to promote male circumcision as a prophylactic measure against HIV, HPV, and other diseases for many years. The Rakai Project produced one of the three deeply flawed RCTs. He has co-authored numerous papers on HIV and circumcision with [[Aaron Tobian]], [[Ronald H. Gray]], [[Maria Wawer]], and other authors. PubMed names Kigozi as an author of | + | Kigozi has been closely associated with the Rakai project to promote male [[circumcision]] as a prophylactic measure against [[HIV]], HPV, and other diseases for many years. The Rakai Project produced one of the [[HIV trials in Africa|three deeply flawed RCTs]]. He has co-authored numerous papers on [[HIV]] and circumcision with [[Aaron Tobian]], [[Ronald H. Gray]], [[Maria Wawer]], and other authors. PubMed names Kigozi as an author of 226 papers, almost all of which promote male circumcision is some way. He is deeply immersed in the promotion of male circumcision. |
| + | |||
| + | == Population-based studies == | ||
| + | {{Population-based studies}} | ||
{{SEEALSO}} | {{SEEALSO}} | ||
* [[Bias]] | * [[Bias]] | ||
| + | {{ABBR}} | ||
{{REF}} | {{REF}} | ||
Latest revision as of 13:21, 21 August 2022
Godfrey Kigozi is member of the 2018 Guideline Development Group (GDG) of the WHO. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.[1]
Biography
The WHO published the following biography of Godfrey Kigozi:
Kigozi, Godfrey
- Rakai Health Sciences Organization, Kampala, Uganda
- MBChB[a 1], Makerere University, Kampala, Uganda;
M.P.H.[a 2], Johns Hopkins Bloomberg School for Public Health, Baltimore, USA;
Ph.D.[a 3], Makerere University/Johns Hopkins Bloomberg School for Public Health.Godfrey Kigozi (M.P.H.[a 2], Ph.D.[a 3]) is Head of Research and Technical advisor for Voluntary Medical Male circumcision (VMMC) at Rakai Health Sciences Program in Uganda.
His focus is on HIV epidemiology and prevention. He has experience in design and conduct of complex research studies including randomized controlled trials, longitudinal cohort studies, and implementation evaluation. He is an investigator on a number NIH and Gates foundation VMMC study protocols that are being implemented in Rakai, Uganda. Godfrey has authored over 150 papers in peer reviewed journals most in the field of VMMC. (https://www.ncbi.nlm.nih.gov/myncbi/collections/mybibliography/?reload=addfrompubmed&sortby=date&groupby=citation_type)
Godfrey has experience in design, implementation and management of HIV prevention programs, including VMMC programs. Godfrey is currently involved in development of a comprehensive national adult and infant VMMC skills training curriculum. The curriculum will be used to equip VMMC providers with skills in provision of safe VMMC using surgical and approved device methods as well as skills to provide emergency resuscitation.[2]
Kigozi has been closely associated with the Rakai project to promote male circumcision as a prophylactic measure against HIV, HPV, and other diseases for many years. The Rakai Project produced one of the three deeply flawed RCTs. He has co-authored numerous papers on HIV and circumcision with Aaron Tobian, Ronald H. Gray, Maria Wawer, and other authors. PubMed names Kigozi as an author of 226 papers, almost all of which promote male circumcision is some way. He is deeply immersed in the promotion of male circumcision.
Population-based studies
September 2021 saw the publication of two huge population studies on the relationship of circumcision and HIV infection:
- Mayan et al. (2021) carried out a massive empirical study of the male population of the province of Ontario, Canada (569,950 males), of whom 203,588 (35.7%) were circumcised between 1991 and 2017. The study concluded that circumcision status is not related to risk of HIV infection.[3]
- Morten Frisch & Jacob Simonsen (2021) carried out a large scale empirical population study in Denmark of 855,654 males regarding the alleged value of male circumcision in preventing HIV and other sexually transmitted infections in men. They found that circumcised men have a higher rate of STI and HIV infection overall than intact men.[4]
No association between lack of circumcision and risk of HIV infection was found by either study. There now is credible evidence that the massive, expensive African circumcision programs have not been effective in preventing HIV infection.
See also
Abbreviations
- ↑
Bachelor of Medicine, Bachelor of Surgery
, Wikipedia. Retrieved 13 October 2021. (Latin: medicinae baccalaureus, baccalaureus chirurgiae; abbreviated in many ways, most commonly MBBS, but also MB ChB, BMBS, MB BCh, MB BChir, and BM BCh.) - ↑ a b
Master of Public Health or Master of Philosophy in Public Health
, Wikipedia. Retrieved 14 June 2021. - ↑ a b
Doctor of Philosophy
, Wikipedia. Retrieved 16 June 2021. (Also abbreviated as D.Phil.)
References
- ↑ (May 2018).
WHO to develop new guidelines on male circumcision
. Retrieved 26 March 2020. - ↑
Biographies of Guideline Development Group (GDG) members for WHO guidance 
, WHO. (September 2018). Retrieved 26 March 2020.
- ↑
Mayan M, Hamilton RJ, Juurlink DN, Austin PC, Jarvi KA. Circumcision and Risk of HIV Among Males From Ontario, Canada. J Urol. 23 September 2021; PMID. DOI. Retrieved 21 August 2022.
Quote:We found that circumcision was not independently associated with the risk of acquiring HIV among men from Ontario, Canada.
- ↑ Frisch M, Simonsen J. Non-therapeutic male circumcision in infancy or childhood and risk of human immunodeficiency virus and other sexually transmitted infections: national cohort study in Denmark. Eur J Epidemiol. 26 September 2021; 37: 251–9. PMID. DOI. Retrieved 16 January 2022.
.svg){kind=icon}
